A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis

Piet Geusens*, Karel Pavelka, Jozef Rovensky, Johan Vanhoof, Nathalie Demeester, Mario Calomme, Dirk Vanden Berghe

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number2
Number of pages12
JournalBMC Musculoskeletal Disorders
Volume18
DOIs
Publication statusPublished - 5 Jan 2017

Keywords

  • Osteoarthritis
  • Knee
  • Choline-stabilized orthosilicic acid
  • WOMAC
  • Cartilage degradation marker
  • Silicon
  • Choline
  • CONTROLLED-TRIAL
  • OARSI RECOMMENDATIONS
  • BIOCHEMICAL MARKERS
  • STRONTIUM RANELATE
  • CONNECTIVE-TISSUE
  • BONE
  • HIP
  • MANAGEMENT
  • DISEASE
  • BIOMARKERS

Cite this